{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:56:17Z","timestamp":1782489377734,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Psychiatry and Behavioral Sciences"},{"DOI":"10.13039\/100015366","name":"McGovern Medical School","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015366","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The University of Texas Health Science Center at Houston (UTHealth)"},{"name":"CNPq (JQ)"},{"name":"FAPESC (JQ)"},{"DOI":"10.13039\/501100013379","name":"Instituto C\u00e9rebro e Mente (JQ)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013379","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UNESC (JQ)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.brainresbull.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T13:46:21Z","timestamp":1478353581000},"page":"29-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain"],"prefix":"10.1016","volume":"128","author":[{"given":"Meysam","family":"Amidfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gislaine Z.","family":"R\u00e9us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ku","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Arbabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2016.11.003_bib0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2005.11.023","article-title":"Evidence for the involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice","volume":"168","author":"Almeida","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0010","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl","key":"10.1016\/j.brainresbull.2016.11.003_bib0015","first-page":"S310","article-title":"Role of the brain-derived neurotrophic factor at glutamatergic synapses","volume":"153","author":"Carvalho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuroscience.2004.06.054","article-title":"Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment","volume":"128","author":"De Foubert","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0025","first-page":"7","article-title":"Depression: the case for a monoamine deficiency","author":"Delgado","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2007-12405","article-title":"Memantine acts as a cholinergic stimulant in the mouse hippocampus","volume":"12","author":"Drever","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0035","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNF.0b013e3180314ae7","article-title":"An open-label, flexible-dose study of memantine in major depressive disorder","volume":"30","author":"Ferguson","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","article-title":"Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression","volume":"33","author":"Feyissa","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0050","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.pnpbp.2009.07.021","article-title":"Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus","volume":"33","author":"Fortunato","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(98)00838-3","article-title":"Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression","volume":"364","author":"Harkin","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.084","article-title":"Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats","volume":"498","author":"Itoh","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","article-title":"Decreased serum brain-derived neurotrophic factor levels in major depressed patients","volume":"109","author":"Karege","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molbrainres.2004.12.020","article-title":"Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs","volume":"136","author":"Karege","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0080","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0028-3908(94)90160-0","article-title":"The effect of tianeptine and sertraline in three animal models of depression","volume":"33","author":"Kelly","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0085","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0022-3565(25)21773-6","article-title":"Sertraline, 1S, 4S-N-methyl-4-(3, 4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin","volume":"226","author":"Koe","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0090","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1124\/jpet.106.103697","article-title":"Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice","volume":"318","author":"Kos","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"\u3010BD-3A\u3011The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1092852900010403","article-title":"Beyond monoamines: glutamatergic function in mood disorders","volume":"10","author":"Kugaya","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0105","first-page":"959","article-title":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","volume":"12","author":"Law","year":"2001","journal-title":"Neurochem. Neurorep."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2006.11.005","article-title":"Decreased plasma BDNF level in depressive patients","volume":"101","author":"Lee","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/187152708786441849","article-title":"Brain adaptation to stressful stimuli: a new perspective on potential therapeutic approaches based on BDNF and NMDA receptors","volume":"7","author":"Marini","year":"2008","journal-title":"CNS Neurol. Disord. \u2013 Drug Targets"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/mcne.2001.1027","article-title":"The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain","volume":"18","author":"Marvanov\u00e1","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential antidepressive properties of amantadine, memantine and bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF02244752","article-title":"Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system","volume":"115","author":"Nixon","year":"1994","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1248\/bpb.32.850","article-title":"Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study","volume":"32","author":"Onogi","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0145","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.brainresbull.2009.11.013","article-title":"Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression?","volume":"81","author":"R\u00e9us","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbr.2011.02.024","article-title":"Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain","volume":"221","author":"R\u00e9us","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3z","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0160","first-page":"778","article-title":"Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression","volume":"59","author":"Rog\u00f3z","year":"2007","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0165","first-page":"817","article-title":"Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats","volume":"60","author":"Rog\u00f3z","year":"2008","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biopsych.2006.11.011","article-title":"Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression","volume":"61","author":"Sattler","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0180","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(96)00169-4","article-title":"Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)","volume":"56","author":"Siuciak","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0190","first-page":"1149","article-title":"Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1, 3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats","volume":"55","author":"Skuza","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/13543784.2012.638916","article-title":"Investigational NMDA receptor modulators for depression","volume":"21","author":"Szewczyk","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainresbull.2012.10.005","article-title":"Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects","volume":"93","author":"Vizi","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0210","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1460-9568.2006.04787.x","article-title":"Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity","volume":"23","author":"Volbracht","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0215","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2016.11.003_bib0220","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A Randomized Trial of an NMDA antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923016302672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923016302672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:23:56Z","timestamp":1759782236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923016302672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":44,"alternative-id":["S0361923016302672"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2016.11.003","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}